Indegene Lifesystems
Tech-native life sciences commercialization specialist founded 1998, offering AI-enabled enterprise commercial, medical, clinical, and technology solutions to global biopharmaceutical, emerging biotech, and medical device companies across 20+ countries.
- Company typePrivate
- Founded1998
- HeadquartersIselin, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Indegene Lifesystems does
Indegene Limited (CIN L73100KA1998PLC102040) is a tech-native life sciences commercialization specialist founded in 1998 and headquartered in Bengaluru, India, with operational headquarters in Iselin/Princeton, New Jersey serving the Americas, London serving Europe, and offices across 20+ locations in Asia Pacific and Latin America. The company orchestrates the full commercialization value chain for life sciences organizations, spanning enterprise commercial, medical, and clinical solutions, with proprietary platforms including Cortex (multi-agent Generative AI), NEXT Technology Platforms (MLR Review Automation, Medical Writing Automation, Regulatory Submissions Planning), Invisage (HCP omnichannel), Connected Content Ecosystem, and Connected Commercial. Customers span global biopharma, emerging biotech, and medical device manufacturers; the company states it is trusted by 20 of the world's top 20 biopharmaceutical companies across the value chain.
The technical stack combines domain-specialized artificial intelligence with operational delivery: AI modalities include text-based generative content and chatbots, machine vision for content modularization and lineage mapping, video generation, avatar-driven audio interfaces, and structured-data analytics for HEOR and pricing. The platform is built on a proprietary data flywheel of approximately 2 million HCPs, 200 million HCP interactions, and 85 million patient records, integrated with major hyperscaler and enterprise technology partners including Veeva (first Digital Factory Accelerator Partner, 149+ certified professionals), AWS, Microsoft, Google, Salesforce, Adobe, Medidata, and Tealium. The company holds CMMI Level 5 and ISO 13485 certifications, with Cybervadis Platinum and EcoVadis Silver sustainability ratings, and consistently ranks as a Leader across Everest Group, ISG, and HFS analyst assessments in life sciences digital and AI services.
The business model is a hybrid of professional services (consulting, transformation, MLR review, medical writing, regulatory operations, pharmacovigilance, omnichannel activation, clinical operations) and technology platform licensing (Cortex, NEXT, Connected Content Ecosystem, Invisage, MME PRMA services, CultHealth agency), delivered through multi-year enterprise contracts with custom, quote-based pricing. Indegene has scaled rapidly via inorganic growth, including the 2021 acquisitions of MME (Pricing, Reimbursement and Market Access, ~$10 million), Trilogy Writing & Consulting, CultHealth, and Encima Group, followed by the 2025 BioPharm acquisition for AI-driven marketing and adtech. The company was capitalized by a $200 million growth round in February 2021 led by Brighton Park Capital and The Carlyle Group.
Indegene Lifesystems firmographics
Firmographics- Name
- Indegene Lifesystems
- Legal name
- Indegene Limited
- Website
- https://indegene.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Tech-native life sciences commercialization specialist founded 1998, offering AI-enabled enterprise commercial, medical, clinical, and technology solutions to global biopharmaceutical, emerging biotech, and medical device companies across 20+ countries.
- Ownership category
- akta.pro rank
Where Indegene Lifesystems is headquartered
LocationHeadquarters
- HQ city
- Iselin
- HQ country
- United States
- HQ region
- North America
Offices20 records
Markets served
Indegene Lifesystems business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Enterprise Solutions Services: Indegene generates revenue through providing integrated life sciences commercialization solutions including enterprise commercial, medical, and clinical solutions. The company offers technology-enabled services across the product lifecycle from clinical development through launch to loss of exclusivity.
- Technology Platform Licensing: Revenue from proprietary platforms including Cortex (GenAI), NEXT MLR Review Automation, Connected Content Ecosystem, and other technology solutions deployed for clients.
- Strategic Consulting: Digital transformation and customer experience consulting services including strategy, operating model design, and technology advisory.
- Omnichannel Activation: Go-to-market services including digital rep equivalence, omnichannel strategy, and customer experience journey design and execution.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise engagement model with custom pricing |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
Indegene Lifesystems product offering
Product offeringCore offering
Indegene is a tech-native life sciences commercialization specialist that orchestrates the path from commercialization strategy through execution, integrating deep domain knowledge, contextualized technology, and operational excellence across clinical, medical, and commercial functions. It sells proprietary technology platforms (Cortex GenAI, NEXT platforms, Connected Content Ecosystem, Invisage omnichannel) alongside enterprise solutions for commercial operations, medical affairs, clinical trials, regulatory submissions, pricing/market access, and omnichannel HCP engagement for biopharma, emerging biotech, and medical device companies.
Product overview
Indegene Lifesystems is a tech-native, life sciences specialist offering a unified portfolio of platforms and services for commercialization strategy through execution. The core offering consists of Enterprise Commercial Solutions, Enterprise Medical Solutions, Enterprise Clinical Solutions, and Technology Solutions, supported by specialized platforms including Cortex (Generative AI), NEXT Technology Platforms (including MLR Review Automation, Regulatory Submissions Planning, and Medical Writing Automation), Connected Commercial, Connected Content Ecosystem, and Agency Of Scale. The company serves biopharmaceuticals, emerging biotech, and medical devices with omnichannel activation capabilities powered by Invisage and Digital Rep Equivalence. Indegene has expanded through acquisitions including Medical Marketing Economics (MME) for PRMA services, Trilogy Writing & Consulting for medical writing, and CultHealth for marketing services.
Differentiator
Problem solved
Functional benefit
Brands
- MME: Pricing, Reimbursement and Market Access (PRMA) advisory services
- CultHealth
- Cortex
- NEXT Technology Platforms
- Trilogy Writing & Consulting
- Invisage
Products and services
- Enterprise Commercial Solutions
- Enterprise Medical Solutions
- Enterprise Clinical Solutions
- Technology Solutions
- Omnichannel Activation Solutions
- Generative AI-Powered Commercialization
- Cortex
- Connected Commercial
- Connected Content Ecosystem
- Agency Of Scale
- NEXT Technology Platforms
- MME (Medical Marketing Economics)
- CultHealth
- DT Consulting
Quantifiable outcome
- Reduces time-to-patient-insights by 80%
- +9 more outcomes
Companies that use Indegene Lifesystems
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Indegene Lifesystems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration12 records
AI capability17 records
Feature9 records
Indegene Lifesystems partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core.
- AdobecoreTechnology partnership for digital experience and content management solutions integration.
- AWS (Amazon Web Services)coreCloud infrastructure partnership for scalable, secure technology solutions deployment.
- GooglecoreTechnology partnership for cloud, AI/ML, and digital transformation solutions.
- MicrosoftcoreAzure cloud and technology partnership for enterprise solutions deployment.
- SalesforcecoreCRM and customer engagement platform integration partnership.
- TealiumcoreCustomer data platform partnership for advanced CDP-driven personalization in healthcare.
- VeevacoreVeeva Certified Partner providing services across Veeva CRM, Vault PromoMats, Approved Email, CLM, Align, CRM Events Management, and Veeva Engage. First partner selected for Veeva's Digital Factory Accelerator Program.
- MedidatacoreEDC platform partnership for clinical data management solutions.
- Trilogy Writing & Consulting GmbHcoreAcquired company with over 22 years of experience providing medical writing services to biopharmaceutical and medical devices industry. Combined with Indegene's core capabilities for effective medical writing practices at scale.
Scale indicators23 records
Recent moves6 records
Expansion highlights6 records
Indegene Lifesystems competitors and assessment
Company assessmentDirect peers
- ZS Associates: ZS Associates is a global professional services firm specializing in sales, marketing, and analytics for life sciences. Direct peer to Indegene with comparable focus on biopharma commercial operations, HCP engagement, and data-driven decision support. Both companies compete for the same top-20 biopharma enterprise accounts.
- Eversana: Eversana is a life sciences commercialization services firm providing market access, patient services, and commercial operations for pharma and emerging biotech. It is a direct peer in commercialization and pricing/market access, and previously employed Indegene SVP Peter Marchesini as President of Field Solutions.
- Axtria: Axtria is a data analytics and software services firm focused exclusively on life sciences commercial operations, including sales, marketing, and patient engagement. It is a direct peer to Indegene in commercial data platforms, HCP targeting, and omnichannel engagement for pharma clients.
- Syneos Health: Syneos Health is a clinical and commercial solutions provider for biopharma, spanning clinical trials, medical affairs, and commercial outsourcing. It is a direct peer in commercialization outsourcing and overlaps with Indegene's connected commercial and omnichannel activation offerings to the same enterprise customers.
Broad incumbents
- IQVIA: IQVIA is the largest global life sciences technology and services provider, spanning clinical development, real-world evidence, and commercial/technology solutions. It is a broad incumbent that overlaps with Indegene in enterprise commercial, medical, and clinical services for the same biopharma customer base.
- Accenture (Life Sciences): Accenture's Life Sciences practice delivers digital transformation, technology, and consulting services to global pharma, including commercial and R&D operations. As a broad incumbent, Accenture competes with Indegene for large multi-year digital transformation and GenAI commercialization engagements with the same top-20 clients.
- Cognizant Life Sciences: Cognizant's Life Sciences practice provides technology, consulting, and business process services to pharmaceutical and medical device companies. It is a broad incumbent that competes with Indegene across enterprise commercial, clinical, and digital transformation engagements.
- Wipro (Life Sciences): Wipro's Life Sciences division delivers IT, digital engineering, and consulting services to pharmaceutical and medical device companies globally. As a broad incumbent with strong India delivery roots similar to Indegene, it competes on large multi-year enterprise contracts and Veeva-adjacent platforms.
- Parexel International: Parexel is a global clinical research organization (CRO) providing clinical development, biostatistics, and regulatory services to biopharma. It is a broad incumbent that overlaps with Indegene's Enterprise Clinical Solutions and regulatory submissions offerings for large pharma and emerging biotech.
Emerging players
- Real Chemistry: Real Chemistry is a health marketing and data analytics agency serving pharma with omnichannel engagement, patient experience, and commercial services. It is an emerging player that overlaps with Indegene in healthcare marketing, content production, and HCP engagement services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks6 records
Key highlights7 records
Customer concentration
Indegene Lifesystems social profiles
Digital presenceIndegene Lifesystems compliance and trust
Trust signalCompliance20 records
Indegene Lifesystems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Indegene Lifesystems leadership team
Management profileNumber of profiles
Profiles16 records
Indegene Lifesystems subsidiaries and ownership
Company hierarchySubsidiaries4 records
Indegene Lifesystems funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Indegene Lifesystems M&A and investment
M&A and investmentM&A6 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Indegene Lifesystems
What does Indegene Lifesystems do?
Indegene is a tech-native life sciences commercialization specialist that orchestrates the path from commercialization strategy through execution, integrating deep domain knowledge, contextualized technology, and operational excellence across clinical, medical, and commercial functions. It sells proprietary technology platforms (Cortex GenAI, NEXT platforms, Connected Content Ecosystem, Invisage omnichannel) alongside enterprise solutions for commercial operations, medical affairs, clinical trials, regulatory submissions, pricing/market access, and omnichannel HCP engagement for biopharma, emerging biotech, and medical device companies.
Is Indegene Lifesystems a public or private company?
Indegene Lifesystems is a private company. It is classified as private equity controlled and is currently operating.
When was Indegene Lifesystems founded?
Indegene Lifesystems was founded in 1998. It employs 1,001 to 5,000 people.
Where is Indegene Lifesystems based?
Indegene Lifesystems is headquartered in Iselin, United States, in the North America region.
How does Indegene Lifesystems make money?
Four revenue lines are on record. Enterprise Solutions Services are the primary driver. The others are technology Platform Licensing, strategic Consulting and omnichannel Activation.
Who are Indegene Lifesystems's main competitors?
Direct peers on record are ZS Associates, Eversana, Axtria and Syneos Health. Broad incumbents are IQVIA, Accenture (Life Sciences), Cognizant Life Sciences, Wipro (Life Sciences) and Parexel International. Real Chemistry is listed as an emerging player.
Does Indegene Lifesystems have an API?
No public API is recorded for Indegene Lifesystems.